Comparative study of zopiclone and pentobarbitone as hypnotics

Area of Science:

• Pharmacology
• Sleep Medicine
• Clinical Trials

Background:

• Insomnia is a prevalent sleep disorder affecting millions globally.
• Pharmacological interventions are common for managing insomnia.
• Comparing the efficacy and safety of different hypnotics is crucial for clinical practice.

Purpose of the Study:

• To compare the efficacy and safety of zopiclone (7.5 mg) and pentobarbitone (100 mg) in adult outpatients with insomnia.
• To evaluate the impact of these medications on sleep onset, duration, awakenings, and quality.
• To assess patient-reported outcomes including therapeutic judgment and morning condition.

Main Methods:

• A randomized controlled trial involving 60 adult outpatients diagnosed with insomnia.
• Patients were assigned to receive either zopiclone or pentobarbitone at bedtime for 16 days.
• Sleep parameters and patient-reported outcomes were assessed and compared against a placebo group.

Main Results:

• Both zopiclone and pentobarbitone significantly improved sleep onset, duration, reduced night awakenings, and enhanced sleep quality compared to placebo.
• Zopiclone showed superiority over pentobarbitone in improving sleep quality, therapeutic judgment, and morning condition.
• Adverse side effects were reported in both groups, but occurred significantly less frequently with zopiclone (p < 0.005).

Conclusions:

• Zopiclone is an effective treatment for sleep disturbances, offering significant improvements in sleep parameters.
• Zopiclone demonstrates better tolerability and fewer side effects compared to pentobarbitone.
• The findings support zopiclone as a useful therapeutic option for managing insomnia due to its efficacy and favorable safety profile.